Sometimes, people are shocked when I say pediatric cancer is a rare disease, but it’s true. In the United States, ...
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.
People with the rare Li-Fraumeni syndrome (LFS) have a high risk of developing cancer. Almost all those affected will develop ...
By Rose Miyatsu The Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the ...
Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the founding of its Scientific Advisory Board (SAB) with ...
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
The following is a summary of "Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and ...
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...
Research presented at the NAPNAP National Conference on Pediatric Health Care explores the benefits of consistent, timely integration of palliative care services at a pediatric neuro-oncology clinic.
The volume of patient-initiated EHR messages “increased dramatically” after the onset of the COVID-19 pandemic and remained elevated through 2022, said A. Jay Holmgren, PhD.
CURE Childhood Cancer invites the community to the Annual Catie’s Gathering in Statesboro on March 15, a sold-out event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback